What conditions does Barbara Ann Karmanos Cancer Institute run trials for?

In our tracked recruiting trials, Barbara Ann Karmanos Cancer Institute sponsors trials for Breast Cancer, Colorectal cancer, Breast Cancer Stage I.

Clinical trials sponsored by Barbara Ann Karmanos Cancer Institute

Recruiting trials

Conditions studied

Phase 1 1Phase 2 2Not applicable 2

Condition	Trials
Breast Cancer	3
Colorectal cancer	3
Breast Cancer Stage I	1
Breast Cancer Stage II	1
Breast Cancer Stage IIIA	1
Colorectal Carcinoma	1
Female Breast Cancer	1
HER2-negative Breast Cancer	1
Hormone Receptor Positive Tumor	1
Intracranial Glioma	1
Metastatic Brain Tumor	1
Metastatic Colorectal Adenocarcinoma	1
Metastatic Pancreatic Adenocarcinoma	1
Neuroendocrine Tumors	1
Pancreatic cancer	1

A Study of the TheraBionic P1 Device in Breast Cancer
NCT07218432 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: Female · 8 locations
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
NCT07130903 · Phase: Phase 2 · Ages: 22 Years and older · Sex: All (male and female) · 9 locations
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT07436078 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 79 Years · Sex: All (male and female) · 3 locations
F-Tryptophan PET/CT in Human Cancers
NCT05556473 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
NCT06576115 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations

Barbara Ann Karmanos Cancer Institute is the lead sponsor of 5 recruiting trials.

No. For the full record, search ClinicalTrials.gov.